Friday, October 18, 2019 6:36:19 AM
There are 3 problems with GRNH, 2 seem to workable and able to be resolved, and 1 major (IMO).
One workable is the cannabis sector has been in a terrible bear market for months, and the second is the debt, which can be resolved.
The major problem with GRNH is that Haas controls the company since he owns 100% of the outstanding Preferred stock, whereas the voting rights give him control.
From the June 30,2019 quarterly statement:
EQUITY Preferred Stock
The Company is authorized to issue10,000,000 shares of preferred stock with a par value of $0.001. The preferred shares entitles the holder equal to i) the greater of 25 votes for each share of Series A Preferred Stock or ii) the number of votes equal to the number of all outstanding shares of common stock, plus one additional vote such that the Series A stock shall always constitute a majority of the voting rights of the Company.
In February of 2012, the Company issued 10,000,000 preferred shares to its chief executive officer and director of the Company, James Haas, for founder related services rendered to the Company. The Shares were valued at par $0.001 which resulted in a founder shares expense of $10,000
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM